TransEnterix (NYSE:TRXC) said yesterday that it submitted an application for 510(k) clearance from the FDA for its SurgiBot robot-assisted surgery device. Research Triangle Park, N.C.-based TransEnterix claims the SurgiBot as the 1st patient-side robotically enhanced laparoscopy platform, designed to be wheeled to a patient’s bedside. "TransEnterix is pleased to deliver on our commitment to file […]
The post TransEnterix submits 510(k) application for Surgibot System appeared first on MassDevice.
from MassDevice http://ift.tt/1ETdsXc
Cap comentari:
Publica un comentari a l'entrada